Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-662-2250
Fax+1 215-615-3995
Dr. Bleiberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin Bleiberg is a medical oncology fellow at the University of Pennsylvania. He completed his residency in Internal Medicine at the University of Pennsylvania Health System from 2020 to 2023 after graduating from the University of Texas Southwestern Medical School in 2020. He holds a BS in Psychology from Duke University. Dr. Bleiberg has authored several publications, including studies on treatments for non-small cell lung cancer and immunotherapy's impact on survival, with works published in journals such as Lung Cancer and JAMA Oncology. His research focuses on clinical epidemiology with an emphasis on treatment selection in the management of thoracic and head and neck malignancies.
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 2020 - 2023
University of Texas Southwestern Medical SchoolClass of 2020
Duke UniversityBS, Psychology, 2010 - 2014
Certifications & Licensure
PA State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Chief Hematology-Oncology Fellow University of Pennsylvania, 2024-2025
- Bradley Award for Clinical Research University of Pennsylvania, 2023
- Herbert Salomon Award in Internal Medicine University of Texas Southwestern Medical Center, 2020
Publications & Presentations
PubMed
- Perioperative Therapy in Oncogene-Driven Non-Small Cell Lung Cancer: Current Strategies and Unanswered Questions.Teja Voruganti, Rosalyn Marar, Benjamin Bleiberg, Edoardo Garbo, Biagio Ricciuti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2025-06-01 - 1 citationsReal-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib.Adam Barsouk, Omar Elghawy, Alec Heidlauf, Connie Yu, Lucy Wang
Lung Cancer. 2024-09-01 - Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?Benjamin A Bleiberg, Charu Aggarwal
JAMA Network Open. 2024-01-02
Grant Support
- Pharmacoepidemiology T32NIH2024–2026
Professional Memberships
- Member
- Member
- Pennsylvania Medical SocietyMember
- Member
- Member
- Member
- International Association for the Study of Lung CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
